Literature DB >> 10708461

Assembly and processing of human immunodeficiency virus Gag mutants containing a partial replacement of the matrix domain by the viral protease domain.

C T Wang1, Y C Chou, C C Chiang.   

Abstract

We constructed human immunodeficiency virus (HIV) mutants by replacing the matrix domain with sequences encoding the viral protease or p6* and protease. The chimeras retaining matrix myristylation and processing signals underwent efficient autoprocessing with severely defective particle budding. The budding defects of the chimeras were rescued by suppressing the chimera protease activity either through addition of an HIV protease inhibitor or through inactivating the chimera protease via a substitution mutation of the catalytic aspartic acid residue. This resulted in the release of chimeric virus-like particles with the density of a wild-type retrovirus particle. In addition, the assembly-competent but processing-defective chimeras produced proteolytically processed particles with significant reverse transcriptase activity when a downstream native pol gene was present. These results suggest that HIV has the potential to adapt heterologous sequences in place of the matrix sequence without major effects on virus-like particle budding. In addition, the positions of the protease and substrate accessibility may contribute significantly toward avoiding a premature Gag or Gag-Pol process, which leads to severe defects in both particle budding and incorporation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708461      PMCID: PMC111845          DOI: 10.1128/jvi.74.7.3418-3422.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

Review 1.  HIV-1 gag proteins: diverse functions in the virus life cycle.

Authors:  E O Freed
Journal:  Virology       Date:  1998-11-10       Impact factor: 3.616

2.  Mutational analysis of a native substrate of the human immunodeficiency virus type 1 proteinase.

Authors:  K Partin; H G Kräusslich; L Ehrlich; E Wimmer; C Carter
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

3.  Incorporation of chimeric gag protein into retroviral particles.

Authors:  R A Weldon; C R Erdie; M G Oliver; J W Wills
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  Standardized and simplified nomenclature for proteins common to all retroviruses.

Authors:  J Leis; D Baltimore; J M Bishop; J Coffin; E Fleissner; S P Goff; S Oroszlan; H Robinson; A M Skalka; H M Temin
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

5.  Characterization of ribosomal frameshifting in HIV-1 gag-pol expression.

Authors:  T Jacks; M D Power; F R Masiarz; P A Luciw; P J Barr; H E Varmus
Journal:  Nature       Date:  1988-01-21       Impact factor: 49.962

6.  The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors.

Authors:  R J Mervis; N Ahmad; E P Lillehoj; M G Raum; F H Salazar; H W Chan; S Venkatesan
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

7.  Analysis of the assembly function of the human immunodeficiency virus type 1 gag protein nucleocapsid domain.

Authors:  Y Zhang; H Qian; Z Love; E Barklis
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

8.  Comparison of the crystal structures and intersubunit interactions of human immunodeficiency and Rous sarcoma virus proteases.

Authors:  I T Weber
Journal:  J Biol Chem       Date:  1990-06-25       Impact factor: 5.157

9.  Rational design of peptide-based HIV proteinase inhibitors.

Authors:  N A Roberts; J A Martin; D Kinchington; A V Broadhurst; J C Craig; I B Duncan; S A Galpin; B K Handa; J Kay; A Kröhn
Journal:  Science       Date:  1990-04-20       Impact factor: 47.728

10.  Cleavage of human immunodeficiency virus type 1 proteinase from the N-terminally adjacent p6* protein is essential for efficient Gag polyprotein processing and viral infectivity.

Authors:  U Tessmer; H G Kräusslich
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

View more
  9 in total

1.  C-Terminal HIV-1 Transframe p6* Tetrapeptide Blocks Enhanced Gag Cleavage Incurred by Leucine Zipper Replacement of a Deleted p6* Domain.

Authors:  Fu-Hsien Yu; Kuo-Jung Huang; Chin-Tien Wang
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

2.  Coding sequences upstream of the human immunodeficiency virus type 1 reverse transcriptase domain in Gag-Pol are not essential for incorporation of the Pr160(gag-pol) into virus particles.

Authors:  Hsu-Chen Chiu; Szu-Yung Yao; Chin-Tien Wang
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  A single amino acid substitution in HIV-1 reverse transcriptase significantly reduces virion release.

Authors:  Chien-Cheng Chiang; Shiu-Mei Wang; Yen-Yu Pan; Kuo-Jung Huang; Chin-Tien Wang
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

4.  Placement of leucine zipper motifs at the carboxyl terminus of HIV-1 protease significantly reduces virion production.

Authors:  Yen-Yu Pan; Shiu-Mei Wang; Kuo-Jung Huang; Chien-Cheng Chiang; Chin-Tien Wang
Journal:  PLoS One       Date:  2012-03-01       Impact factor: 3.240

5.  HIV-1 matrix domain removal ameliorates virus assembly and processing defects incurred by positive nucleocapsid charge elimination.

Authors:  Li-Jung Ko; Fu-Hsien Yu; Kuo-Jung Huang; Chin-Tien Wang
Journal:  FEBS Open Bio       Date:  2015-04-09       Impact factor: 2.693

6.  Gag-Pol Transframe Domain p6* Is Essential for HIV-1 Protease-Mediated Virus Maturation.

Authors:  Fu-Hsien Yu; Ting-An Chou; Wei-Hao Liao; Kuo-Jung Huang; Chin-Tien Wang
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

7.  HIV-1 Mutant Assembly, Processing and Infectivity Expresses Pol Independent of Gag.

Authors:  Fu-Hsien Yu; Kuo-Jung Huang; Chin-Tien Wang
Journal:  Viruses       Date:  2020-01-02       Impact factor: 5.048

8.  APOBEC3G cytidine deaminase association with coronavirus nucleocapsid protein.

Authors:  Shui-Mei Wang; Chin-Tien Wang
Journal:  Virology       Date:  2009-04-05       Impact factor: 3.616

9.  HIV-1 matrix protein repositioning in nucleocapsid region fails to confer virus-like particle assembly.

Authors:  Ching-Yuan Chang; Yu-Fen Chang; Shiu-Mei Wang; Ying-Tzu Tseng; Kuo-Jung Huang; Chin-Tien Wang
Journal:  Virology       Date:  2008-06-12       Impact factor: 3.616

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.